TEMPERATURE AND FORWARD MOVEMENT OF PARAMECIUM

1. The rate of forward movement in Paramecium as affected by changes in temperature can be described accurately in terms of the Arrhenius equation. See PDF for Equation 2. For the range from 6–15°, µ = 16,000; from 16–40°, µ = 8,000. These values fall within the limits characteristic for chemical processes. 3. On the principle of velocity control by the slowest rate, it is assumed that in Paramecium at temperatures above normal, control passes from one underlying reaction to another. 4. The views expressed by Rice, the recent results of Crozier, and certain µ values given by Arrhenius all suggest that µ = 16,000 may represent an oxidation, and µ = 8,000 either a modified oxidation or an hydrolysis. 5. For the system of controls, the catenary series O → A → E with the lower µ value attached to the precursor reaction is adequate. We may also assume a cyclical system analogous to Meyerhof''s conception of carbohydrate metabolism in muscle. In this case it is necessary to assign µ = 16,000 to the oxidation of A and E and µ = 8,000 to the synthesis E → O. This model also accounts for the fact that the data might be interpreted as involving, apparently, a depletion of A at the higher temperature.     

Purification and characterization of an 85 kDa talin-binding fragment of vinculin

Vinculin and talin are adhesion plaque proteins which have been shown to interact with each other in vitro. In order to begin to investigate where the talin-binding domain is in vinculin, vinculin was digested with Staphylococcus aureus V8 protease to generate two major fragments of 85 and 30 kDa, and these fragments were purified. Nitrocellulose overlays with 125I-talin and the 125I-85 kDa vinculin fragment and sucrose density gradient centrifugation demonstrated that the talin-binding domain was localized to the 85 kDa vinculin fragment. Quantification of 125I-talin binding in the overlays showed that four times more talin bound to the 85 kDa fragment as compared to intact vinculin. Competitive immunoprecipitation experiments demonstrated that unlabeled 85 kDa fragment was about three-fold more effective at competing for 125I-85 kDa binding to talin than was unlabeled vinculin. These results suggest that the 30 kDa fragment inhibits the vinculin-talin interaction even though the talin-binding domain is localized in the 85 kDa fragment.     

Prinzipien und Beispiele der Anwendung phytoserologischer Methodik

Ohne ZusammenfassungMit 13 Textabbildungen.     

Signalling and the control of skeletal muscle size

Skeletal muscle is highly adaptive to environmental stimuli and can alter its mass accordingly. This tissue is almost unique in that it can increase its size through two distinct mechanisms. It can grow through a cellular process mediated by cell fusion, or it can increase its size simply by increasing its protein content. Understanding how these processes are regulated is crucial for the development of potential therapies against debilitating skeletal muscle wasting diseases. Two key signalling molecules, Insulin like Growth Factor (IGF) and GDF-8/myostatin, have emerged in recent years to be potent regulators of skeletal muscle size. In this review we bring together recent data highlighting the important and novel aspects of both molecules and their signalling pathways, culminating in a discussion of the cellular and tissue phenotypic outcomes of their stimulation or antagonism. We emphasise the complex regulatory mechanisms and discuss the temporal and spatial differences that control their action, understanding of which is crucial to further their use as potential therapeutic targets.